Report: Value of PET in malignant melanoma cannot be assessed yet

07/21/2011 | Medical News Today

A report published by the German Institute for Quality and Efficiency in Health Care concluded that the value of PET and PET/CT in diagnosing malignant melanoma cannot be determined because of a lack of meaningful studies. A search of international scientific literature for studies that explore the effect of PET or PET/CT on the health of patients did not turn up any relevant studies, according to the report. Seventeen diagnostic accuracy studies were discovered, but the diagnostic accuracy of the methods differed significantly in those studies, the report also found.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT